Summary
We have studied the pharmacokinetics of methotrexate in patients with rheumatoid arthritis concurrently treated with choline magnesium trisalicylate, ibuprofen, naproxen, or a non-NSAID analgesic (control treatment).
The apparent systemic clearance of methotrexate was significantly reduced by all three treatments. Trisalicylate and ibuprofen both significantly reduced methotrexate renal clearance, but only the trisalicylate significantly displaced methotrexate from protein, increasing the fraction unbound by 28%.
These data show that NSAIDs can affect the disposition of methotrexate, possibly increasing the potential for toxicity and necessitating dosage adjustments. However, large inter-subject variability precludes specific dosage recommendations.
Similar content being viewed by others
References
Health and Public Policy Committee, American College of Physicians (1987) Methotrexate in rheumatoid arthritis. Ann Intern Med 107: 418–419
Furst DE, Kremer JM (1988) Methotrexate in rheumatoid arthritis. Arth Rheum 31: 305–314
Tugwell P, Bennett K, Gent M (1987) Methotrexate in rheumatoid arthritis: indications, contraindications, efficacy and safety. Ann Intern Med 107: 358–366
Hall S, Buchbinder R, Harkness A, Littlejohn G, Miller M, Ryan P (1988) Safety and efficacy of low dosage long term methotrexate in rheumatoid arthritis assessed by lifetable analysis of treatment terminations (abstract). Arth Rheum 31 [Suppl]: S116
Weinblatt ME, Trentham DE, Fraser PA, Holdworth DE, Falcheck KR, Weissman BN, Coblyn JS (1988) Long term prospective trial of low dose methotrexate in rheumatoid arthritis. Arth Rheum 31: 167–175
Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill I (1989) Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16: 313–320
Stewart CF, Fleming RA, Arkin CR, Evans WE (1990) Coad-ministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 47: 540–546
Nierenberg DW (1983) Competitive inhibition of methotrexate in rabbit kidney slices by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 226: 1–6
Nuernberg B, Koehnke R, Solsky M, Hoffman J, Furst DE (1990) Biliary elimination of low-dose methotrexate in humans. Arth Rheum 1990; 33: 898–902
Creaven PJ, Hansen HH, Alford DA, Allen LM (1973) Methotrexate in liver and bile after intravenous dosage in man. Br J Canc 28: 589–591
Liegler DG, Henderson ES, Hahn MA, Oliverio VT (1969) The effect of organic acids on renal clearance of methotrexate in man. Clin Pharmacol Ther 10: 849–857
Furst D, Herman R, Koehnke R, Ericksen N, Hash L, Riggs CE, Porras A, Veng-Pedersen P (1990) The effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 79: 782–786
Skeith KJ, Russell AS, Jamali F, Coates J (1990) Lack of significant interaction between low-dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 17: 1008–1010
Singh RR, Malaviya AN, Pandey JN, Guleria JS (1986) Fatal interaction between methotrexate and naproxen. Lancet I: 1390
Daly H, Boyle J, Roberts C, Scott G (1986) Interaction between methotrexate and nonsteroidal anti-inflammatory drugs. Lancet I: 559
MacKinnon SK, Starkebaum G, Willkens RF (1985) Pancytopenia associated with low-dose pulse methotrexate in the treatment of rheumatoid arthritis. Semin Arth Rheum 15: 119–136
Tracy TS, Jones DR, Hall SD, Brater DC, Bradley JD, Krohn K (1990) The effect of NSAIDs on methotrexate disposition in patients with rheumatoid arthritis. Clin Pharmacol Ther 47: 138
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31: 315–324
Sand TE, Jacobsen S (1981) Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol 19: 453–456
Chiou WL (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule for the calculation of the area under the plasma concentration time curve. J Pharmacokinet Biopharm 6: 539–546
Einot I, Gabriel KR (1975) A study of the powers of several methods of multiple comparisons. J Am Stat Assoc 70: 351
Albert KS, Gernaat CM (1984) Pharmacokinetics of ibuprofen. Am J Med 71A: 40–46
Runkel RA, Forchielli E, Sevelius H, Chaplin M, Segre E (1974) Nonlinear plasma level response to high doses of naproxen. Clin Pharmacol Ther 15: 261–266
Wosilait W (1976) Theoretical analysis of the binding of salicylate by human serum albumin. The relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285–290
Sjoholm I (1986) The specificity of drug binding sites on human serum albumin. In: Reidenberg MM, Erill S (eds) Drug-protein binding, Praeger Scientific, New York, pp 36–44
Sudlow G, Birkett DJ, Wade DN (1976) Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12: 1052–1061
Hall SD, Rowland M (1985) Influence of fraction unbound upon the renal clearance of furosemide in the isolated perfused rat kidney. J Pharmacol Exp Ther 232: 263–268
Runkel R, Forchielli E, Boost G, Chaplin M, Hill R, Sevelius H, Thompson G, Segre E (1973) Naproxen metabolism, excretion and comparative pharmacokinetics. Scand J Rheum [Suppl] 2: 29–36
Levy G, Tsuchiya T, Amsel LP (1972) Limited capacity of salicylphenolic glucuronide formation and its effects on the kinetics of salicylate elimination in man. Clin Pharmacol Ther 13: 258–268
Koch PA, Schultz CA, Wills RJ, Hallquist SL, Welling PG (1978) Influence of food and fluid ingestion on aspirin bioavailability. J Pharm Sci 67: 1533–1535
Herman RA, Veng-Pedersen P, Hoffman J, Koehnke R, Furst DE (1989) Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci 78: 165–171
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tracy, T.S., Krohn, K., Jones, D.R. et al. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur J Clin Pharmacol 42, 121–125 (1992). https://doi.org/10.1007/BF00278469
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00278469